223 related articles for article (PubMed ID: 19026117)
1. Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51.
Yasuoka H; Yamaguchi Y; Mizuki N; Nishida T; Kawakami Y; Kuwana M
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S59-63. PubMed ID: 19026117
[TBL] [Abstract][Full Text] [Related]
2. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
[TBL] [Abstract][Full Text] [Related]
3. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS).
Freysdottir J; Lau S; Fortune F
Clin Exp Immunol; 1999 Dec; 118(3):451-7. PubMed ID: 10594567
[TBL] [Abstract][Full Text] [Related]
4. Increased senescent CD8+ T cells in the peripheral blood mononuclear cells of Behçet's disease patients.
Yang JY; Park MJ; Park S; Lee ES
Arch Dermatol Res; 2018 Mar; 310(2):127-138. PubMed ID: 29255925
[TBL] [Abstract][Full Text] [Related]
5. Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.
Clemente A; Cambra A; Munoz-Saá I; Crespí C; Pallarés L; Juan A; Matamoros N; Julià MR
Immunol Lett; 2010 Apr; 129(2):57-63. PubMed ID: 20167234
[TBL] [Abstract][Full Text] [Related]
6. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
7. Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers.
Bank I; Duvdevani M; Livneh A
J Lab Clin Med; 2003 Jan; 141(1):33-40. PubMed ID: 12518166
[TBL] [Abstract][Full Text] [Related]
8. Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behçet's Disease with Arthritis.
Islam SMS; Kim HA; Choi B; Jung JY; Lee SM; Suh CH; Sohn S
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614573
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic abnormalities of peripheral blood mononuclear cells in patients with Behçet's disease and association with HLA-B51 expression.
Sakly K; Lahmar R; Nefzi F; Hammami S; Harzallah O; Sakly N; Sakly W; Hassine M; Mahjoub S; Ghedira I; Feki S
Immunol Invest; 2014; 43(5):463-78. PubMed ID: 24661088
[TBL] [Abstract][Full Text] [Related]
10. CD11c is upregulated in CD8+ T cells of patients with Behçet's disease.
Park YJ; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S86-S91. PubMed ID: 27309860
[TBL] [Abstract][Full Text] [Related]
11. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease.
Kibaroglu A; Eksioglu-Demiralp E; Akoglu T; Direskeneli H
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S59-63. PubMed ID: 15515788
[TBL] [Abstract][Full Text] [Related]
12. Insufficient expression of Fas antigen on helper T cells in Behçet's disease.
Nakamura S; Sugita M; Matoba H; Tanaka S; Isoda F; Ohno S
Br J Ophthalmol; 1996 Feb; 80(2):174-6. PubMed ID: 8814751
[TBL] [Abstract][Full Text] [Related]
13. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease.
Pervin K; Childerstone A; Shinnick T; Mizushima Y; van der Zee R; Hasan A; Vaughan R; Lehner T
J Immunol; 1993 Aug; 151(4):2273-82. PubMed ID: 7688396
[TBL] [Abstract][Full Text] [Related]
14. HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea.
Chang HK; Kim JU; Cheon KS; Chung HR; Lee KW; Lee IH
Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S31-5. PubMed ID: 11760395
[TBL] [Abstract][Full Text] [Related]
15. Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation.
Freysdottir J; Hussain L; Farmer I; Lau SH; Fortune F
Oral Dis; 2006 May; 12(3):271-7. PubMed ID: 16700735
[TBL] [Abstract][Full Text] [Related]
16. Proliferative response of CD8+ gamma delta+ T cells to Streptococcus sanguis in patients with Behçet's disease.
Nishida T; Hirayama K; Nakamura S; Ohno S
Ocul Immunol Inflamm; 1998 Sep; 6(3):139-44. PubMed ID: 9785603
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies.
Kahan A; Hamzaoui K; Ayed K
J Rheumatol; 1992 May; 19(5):742-6. PubMed ID: 1377274
[TBL] [Abstract][Full Text] [Related]
18. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
[TBL] [Abstract][Full Text] [Related]
19. The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis.
Yu HG; Lee DS; Seo JM; Ahn JK; Yu YS; Lee WJ; Chung H
Clin Exp Immunol; 2004 Aug; 137(2):437-43. PubMed ID: 15270864
[TBL] [Abstract][Full Text] [Related]
20. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
